- $8.37m
- $7.85m
- $0.17m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.71 | ||
| Price to Tang. Book | 13.75 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 97.18 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -379.45% | ||
| Return on Equity | -164.89% | ||
| Operating Margin | -5495.06% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.06 | 0.67 | 0.7 | 0.85 | 0.17 | n/a | n/a | 62.08% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Amesite Inc. is a technology company. The Company is specialized in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. It has products in two sectors: Higher Education and Healthcare. It offers cutting-edge applications that cater to both individual and professional needs. The Company’s NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 14th, 2017
- Public Since
- September 25th, 2020
- No. of Shareholders
- 41
- No. of Employees
- 9
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Capital Market- Shares in Issue
- 3,994,107
- Address
- 205 East Washington Street, Suite B, ANN ARBOR, 48104
- Web
- https://amesite.com/
- Phone
- +1 7348768130
- Contact
- Mj Clyburn
- Auditors
- Turner, Stone & Company
Upcoming Events for AMST
Q4 2025 Amesite Inc Earnings Release
Similar to AMST
180 Life Sciences
NASDAQ Capital Market
36Kr Holdings
NASDAQ Capital Market
3 E Network Technology
NASDAQ Capital Market
A2Z Cust2mate Solutions
NASDAQ Capital Market
Abits
NASDAQ Capital Market
FAQ
What is the Amesite share price?
As of Today at 19:15 UTC, shares in Amesite are trading at $2.10. This share price information is delayed by 15 minutes.
How has the Amesite share price performed this year?
Shares in Amesite last closed at $2.10 and the price had moved by +6.9% over the past 365 days. In terms of relative price strength the Amesite share price has outperformed the S&P500 Index by +0.51% over the past year.
What are the analyst and broker recommendations for Amesite?
The overall consensus recommendation for Amesite is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Amesite dividend yield?
Amesite does not currently pay a dividend.
Does Amesite pay a dividend?
Amesite does not currently pay a dividend.
When does Amesite next pay dividends?
Amesite does not currently pay a dividend.
How do I buy Amesite shares?
To buy shares in Amesite you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Amesite?
As of the previous close price of $2.10, shares in Amesite had a market capitalisation of $8.37m.
Where are Amesite shares listed?
Here are the trading details for Amesite:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: AMST
What kind of share is Amesite?
Based on an overall assessment of its quality, value and momentum Amesite is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Amesite share price forecast for 2025?
The analyst consensus target price for shares in Amesite is $7.00. That is 234.1% above the last closing price of $2.10.
Analysts covering Amesite currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Amesite share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Amesite. Over the past six months, its share price has underperformed the S&P500 Index by -9.66%.
As of the last closing price of $2.10, shares in Amesite were trading -25.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Amesite PE Ratio?
The Amesite PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Amesite?
We do not have data on Amesite's directors